Randox Laboratories Ltd. is a privately owned diagnostic reagent and equipment manufacturer. Established in 1982 Randox is a multimillion pound business employing over 600 people, including 185 research scientists. Randox's success has been built on the philosophy – ‘that we exist and expand through our customers’.
Randox have sales and distribution agreements in 130 countries and international offices with representation in the continents of Africa, Asia, Australia, Europe, North America and South America. Randox develops, manufactures and markets a wide range of clinical diagnostic products for laboratory medicine. The core products and services are Biochip Array Technology, clinical chemistry automation systems, external quality assurance schemes, Internet driven QA systems, quality control materials, clinical reagents and environmental diagnostics.
Randox Laboratories goal is to continue investing in the development of new healthcare technology solutions to improve disease diagnosis and patient care.
Clinical Chemistry Reagents, Dedicated Diagnostics Reagents, Virology Assay Reagents, Free Radical Assay Reagents, Quality Control Materials, Internet Driven QA systems (Randox 247 Programme), External Quality Assurance Schemes (RIQAS Programme), Clinical Chemistry Automation System (RX Daytona), Biochip Array Technology Analyzer (Evidence®)